Paclitaxel extravasation treated with systemic corticosteroids-Reference-Cited by-同舟云学术

Paclitaxel extravasation treated with systemic corticosteroids

Published:2022-12-01 Issue:12 Volume:47 Page:2295-2296
ISSN:1365-2230
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Cheour Mouna¹,Belajouza Colandane¹,Manaa Linda¹^ORCID,Lahouel Maha¹^ORCID,Fetoui Nedia Ghariani¹,Mokni Sana¹,Ghariani Najet¹,Aounallah Amina¹,Denguezli Mohamed¹

Affiliation:

1. Department of Dermatology Farhat Hached University Hospital University of Sousse Sousse Tunisia

Abstract

Abstract Chemotherapy extravasation is a rare but severe cutaneous complication associated with administration of intravenous chemotherapy. Extravasation causes serious disability and diminishes the quality of life in patients with cancer undergoing antineoplastic therapy. Treatment of chemotherapy extravasation is not standardized. We report a patient with paclitaxel extravasation who was successfully treated with corticosteroids.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.15348

Reference5 articles.

1. Overview, prevention and management of chemotherapy extravasation;Kreidieh;World J Clin Oncol,2016

2. Dermatological adverse events with taxane chemotherapy;Sibaud;Eur J Dermatol,2016

3. Extravasation of chemotherapeutic agents: prevention and treatment;Goolsby;Semin Oncol,2006

4. A review of clinical experience with paclitaxel extravasations;Stanford;Support Care Cancer,2003

5. Taxanes: vesicants, irritants, or just irritating?;Barbee;Ther Adv Med Oncol,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel;Reactions Weekly;2023-01-21